David Rosen, a partner and member of the Life Sciences and Nanotechnology Industry Teams, will be moderating a panel for the Tech Council of Maryland entitled, “Nanomedicine, Opportunities and Challenges.” The session will be taking place at John Hopkins University on September 12, 2007.
The panel will discuss the promises as well as some of the challenges are to creating these new therapies that may be safer and more effective in treating life-threatening diseases.
Panelists include:
Dr. Hamid Ghandehari, Director, University of Maryland School of Pharmacy, Center for Nanomedicine and Cellular Delivery, Department of Pharmaceutical Sciences
Dr. Chiming Wei, Department of Surgery, The Johns Hopkins School of Medicine and President, American Academy of Nanomedicine
Dr. Lawrence Tamarkin, President & CEO, CytImmune Sciences, Inc.
